Changing Healthcare for Millions of Patients Open Innovation and Partnership

Our open innovation and partnership strategy is designed to improve healthcare across the globe by sharing expertise, resources, intellectual property and know-how with the scientific community and healthcare providers.

Distributor Partnership

Become one of our distribution and training partners around the world to help us reach 100 Million patients with sam® treatment.

The sam® family of ultrasound products are the only FDA-cleared multi-hour wearable ultrasound delivery devices in the world. sam® Pro 2.0 was introduced into the United States market in 2018 and its’ predecessor sam® Sport in 2014 which are protected by 46 global patent filings, registrations and trademarks. The medical device is the first of its’ kind to use a patented sustained acoustic medicine (sam) algorithm that provides 18,720 Joules of energy over a daily 4 hour treatment accelerating soft-tissue healing (blood vessel development, collagen matrix rebuilding and cellular remodeling) and reducing inflammation and pain.

Research Partnership

PFATS 2

Long Duration Ultrasound Innovation

Pain Management

Drug Delivery

Soft Tissue Healing

Wound Healing

Oncology